Cilengitide targeting of αvβ3 integrin receptor synergizes with radioimmunotherapy to increase efficacy and apoptosis in breast cancer xenografts

Patricia A. Burke, Sally J. DeNardo, Laird A. Miers, Kathleen R. Lamborn, Siegfried Matzku, Gerald L Denardo

Research output: Contribution to journalArticlepeer-review

214 Scopus citations

Fingerprint Dive into the research topics of 'Cilengitide targeting of α<sub>v</sub>β<sub>3</sub> integrin receptor synergizes with radioimmunotherapy to increase efficacy and apoptosis in breast cancer xenografts'. Together they form a unique fingerprint.

Medicine & Life Sciences